Results 121 to 130 of about 10,193 (191)
Treatment of Langerhans Cell Histiocytosis
Histiocytosis X patients present with a variety of clinical manifestations and outcomes. The principal difficulty in the establishment of a definite protocol for treatment is based on the poor understanding of the basic nature of this disease, the ...
김현우, 신규호
core
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. [PDF]
Janku F +9 more
europepmc +1 more source
Langerhans cell histiocytosis (LCH) is a rare disorder affecting predominantly children and manifesting as bone pains, bony swellings and lytic lesions. Involvement of vertebrae as presenting manifestation is unusual.
Agarwal, V., Nityanand, S.
core +1 more source
: The synchronous or metachronous development of Langerhans cell histiocytosis and non-Langerhans cell histiocytosis in the same patient is rare. To date, only seven cases of xanthogranulomas developing in young patients with a history of Langerhans cell
Klaus-Daniel Stachel +3 more
core
Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration. [PDF]
Hershkovitz-Rokah O +3 more
europepmc +1 more source
Case report: Pulmonary non-Langerhans cell histiocytosis in a dog with acute interstitial granulomatous pneumonia. [PDF]
Granger KL +4 more
europepmc +1 more source
Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.
Langerhans cell histiocytosis is a disorder characterized by lesions that include CD207+ dendritic cells along with an inflammatory infiltrate. Langerhans cell histiocytosis has a highly variable clinical presentation, ranging from a single lesion to ...
Allen, Carl E +2 more
core
Extensive reactive cutaneous histiocytic infiltrate resembling non-Langerhans cell histiocytosis as the presenting sign of underlying vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. [PDF]
Wang CX +3 more
europepmc +1 more source

